These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2675082)

  • 1. Iron chelation.
    Hershko C; Link G; Pinson A
    Prog Clin Biol Res; 1989; 309():133-40. PubMed ID: 2675082
    [No Abstract]   [Full Text] [Related]  

  • 2. High-dose intravenous chelation therapy with deferoxamine.
    Cohen A; Mizanin J; Schwartz E
    Prog Clin Biol Res; 1989; 309():125-31. PubMed ID: 2780746
    [No Abstract]   [Full Text] [Related]  

  • 3. Oral iron chelators.
    Nathan DG; Piomelli S
    Semin Hematol; 1990 Apr; 27(2):83-5. PubMed ID: 2190320
    [No Abstract]   [Full Text] [Related]  

  • 4. Medical management of beta-thalassemia.
    Lerner N
    Prog Clin Biol Res; 1989; 309():13-22. PubMed ID: 2780747
    [No Abstract]   [Full Text] [Related]  

  • 5. Compliance with therapy in Cooley's anaemia.
    Vullo C; Di Palma A
    Prog Clin Biol Res; 1989; 309():43-9. PubMed ID: 2780749
    [No Abstract]   [Full Text] [Related]  

  • 6. Outcomes, utilization, and costs among thalassemia and sickle cell disease patients receiving deferoxamine therapy in the United States.
    Delea TE; Hagiwara M; Thomas SK; Baladi JF; Phatak PD; Coates TD
    Am J Hematol; 2008 Apr; 83(4):263-70. PubMed ID: 17924547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of iron status.
    Pippard MJ
    Prog Clin Biol Res; 1989; 309():85-92. PubMed ID: 2675108
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiac complications in homozygous beta-thalassemia.
    Wonke B; Hoffbrand AV; Aldouri MA; Ward SE
    Prog Clin Biol Res; 1989; 309():51-6. PubMed ID: 2780750
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatic iron stores in thalassemia: non-invasive magnetic measurements.
    Brittenham GM; Allen CJ; Farrell DE; Harris JW
    Prog Clin Biol Res; 1989; 309():101-6. PubMed ID: 2780744
    [No Abstract]   [Full Text] [Related]  

  • 10. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine.
    Borgna-Pignatti C; Rugolotto S; De Stefano P; Zhao H; Cappellini MD; Del Vecchio GC; Romeo MA; Forni GL; Gamberini MR; Ghilardi R; Piga A; Cnaan A
    Haematologica; 2004 Oct; 89(10):1187-93. PubMed ID: 15477202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical management of beta-thalassemia.
    Graziano J; Piomelli S
    Tex Rep Biol Med; 1980-1981; 40():355-64. PubMed ID: 7034276
    [No Abstract]   [Full Text] [Related]  

  • 12. Iron chelation.
    Chandy M
    J Assoc Physicians India; 1991 Sep; 39(9):665-6. PubMed ID: 1814896
    [No Abstract]   [Full Text] [Related]  

  • 13. Correction of anemia in a transfusion-dependent patient with primary myelofibrosis receiving iron chelation therapy with deferasirox (Exjade, ICL670).
    Di Tucci AA; Murru R; Alberti D; Rabault B; Deplano S; Angelucci E
    Eur J Haematol; 2007 Jun; 78(6):540-2. PubMed ID: 17391307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfusion haemosiderosis and chelation therapy.
    Ley TJ; Griffith P; Nienhuis AW
    Clin Haematol; 1982 Jun; 11(2):437-64. PubMed ID: 7042160
    [No Abstract]   [Full Text] [Related]  

  • 15. Quality of life and life expectancy in thalassemic patients with complications.
    Gabutti V; Piga A; Sacchetti L; Sandri A; Biginelli M; Saracco P; Ferri M
    Prog Clin Biol Res; 1989; 309():35-41. PubMed ID: 2780748
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of iron-chelating agents in cultured heart muscle cells. Identification of a potential drug for chelation therapy.
    Sciortino CV; Byers BR; Cox P
    J Lab Clin Med; 1980 Dec; 96(6):1081-5. PubMed ID: 7430764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thalassemia.
    Brown EB
    Prog Clin Biol Res; 1983; 127():33-42. PubMed ID: 6889403
    [No Abstract]   [Full Text] [Related]  

  • 18. Iron metabolism and iron chelation in the thalassaemia disorders.
    Pippard MJ
    Haematologica; 1990; 75 Suppl 5():66-71. PubMed ID: 2086383
    [No Abstract]   [Full Text] [Related]  

  • 19. Endocrine complications in thalassaemia major.
    De Sanctis V; Vullo C; Katz M; Wonke B; Hoffbrand VA; Di Palma A; Bagni B
    Prog Clin Biol Res; 1989; 309():77-83. PubMed ID: 2780752
    [No Abstract]   [Full Text] [Related]  

  • 20. Liver iron stores before and after bone marrow transplantation for thalassemia.
    Politi P; Lucarelli G; Capriotti L; Salvadori P; Dardanelli C; Barbanti I
    Prog Clin Biol Res; 1989; 309():281-9. PubMed ID: 2675096
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.